Atherectomy Devices Market Growth and Demand Forecast 2024-2032

IMARC Group’s report titled “Atherectomy Devices Market Report by Product (Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices) Application (Peripheral Vascular, Cardiovascular, Neurovascular), End User (Hospitals, Ambulatory Surgery Centers, Research Laboratories and Academic Institutes), and Region 2024-2032”, The global atherectomy devices market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

Grab a sample PDF of this report: https://www.imarcgroup.com/atherectomy-devices-market/requestsample

Factors Affecting the Growth of the Atherectomy Devices Industry:

• Increasing Prevalence of Cardiovascular Diseases:

As more individuals are diagnosed with cardiovascular diseases, such as peripheral artery disease (PAD), coronary artery disease (CAD), and other forms of atherosclerosis, the demand for effective treatment options is rising. Atherectomy devices, which are used to remove atherosclerotic plaque from blood vessels, become more necessary as these conditions become more prevalent. Advancements in diagnostic technologies and increased screening efforts lead to early detection of CVDs. Early diagnosis often means that more patients can benefit from interventional procedures like atherectomy before their conditions become severe, thereby increasing the use of these devices.

• Technological Advancements:

Innovations in atherectomy technology are leading to the development of more effective devices that can more precisely and safely remove atherosclerotic plaque. Improvements in cutting, laser, and rotational mechanisms allow for better outcomes, making these devices more attractive to healthcare providers. Technological progress is enabling atherectomy devices to be used in minimally invasive procedures. This results in shorter recovery times, reduced hospital stays, and lower risk of complications for patients, increasing the adoption of atherectomy procedures.

• Minimally Invasive Procedures:

Minimally invasive atherectomy procedures generally involve smaller incisions, leading to faster patient recovery times. This is a major benefit for patients, allowing them to return to their normal activities more quickly compared to traditional open surgeries. These procedures typically have fewer complications, such as infections and excessive bleeding, compared to more invasive surgeries. This safety profile makes atherectomy a preferred option for both patients and healthcare providers.

We explore the factors propelling the atherectomy devices market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading Companies Operating in the Global Atherectomy Devices Industry:

• Abbott Laboratories
• Avinger
• B. Braun Melsungen AG
• Biomerics
• Biotronik
• Boston Scientific Corporation
• C.R. Bard (Becton, Dickinson and Company)
• Cardinal Health, Koninklijke Philips N.V.
• Medtronic, Minnetronix Inc.
• Straub Medical AG (Becton, Dickinson and Company)
• Terumo Corporation.

Atherectomy Devices Market Report Segmentation:

By Product:

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Photo-Ablative Atherectomy Devices
• Rotational Atherectomy Devices
• Support Devices

Directional atherectomy devices represent the largest segment as directional atherectomy devices are favored for their ability to precisely target and remove plaque, appealing to healthcare providers seeking effective treatment options for peripheral artery disease and coronary artery disease.

By Application:

• Peripheral Vascular
• Cardiovascular
• Neurovascular

Peripheral vascular accounts for the majority of the market share due to the increasing prevalence of peripheral artery disease globally, driving the demand for atherectomy devices specifically designed for treating arteries outside the heart and brain.

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Research Laboratories and Academic Institutes

Hospitals hold the biggest market share owing to their infrastructure and capacity to perform complex cardiovascular procedures, including atherectomy, which requires specialized equipment and skilled healthcare professionals.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the atherectomy devices market on account of high healthcare expenditure, advanced healthcare infrastructure, early adoption of technological innovations, and a significant prevalence of cardiovascular diseases prompting the demand for atherectomy procedures and devices.

Global Atherectomy Devices Market Trends:

The rising incidence of cardiovascular diseases, such as peripheral artery disease (PAD) and coronary artery disease (CAD), is fueling the demand for atherectomy devices as effective treatment options. There is a growing preference for minimally invasive procedures due to their benefits, including shorter recovery times, reduced hospital stays, and lower risk of complications, which is boosting the adoption of atherectomy devices. The proliferation of ASCs globally, equipped to perform minimally invasive procedures like atherectomy, is expanding patient access and driving market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
 Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145